Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Je Il researchers disclose tricyclic derivatives of colchicine for use in cancer therapy

March 8, 2005

Femara receives new approval in Germany

March 8, 2005

U.K. approval for phase I study of Reolysin in combination with radiation

March 8, 2005

In vitro evidence for an IGF-1R blocker, NVP-ADW-742, in the treatment of Ewing tumor

March 8, 2005

Lenalidomide reported effective in multiple myeloma

March 8, 2005

MJ-III-65 displays in vivo antitumor activity

March 8, 2005

Novel combinations of anticancer agents reported by Angiogene researchers

March 7, 2005

An endogenous cannabinoid prevents prostate cancer cell invasion

March 7, 2005

Parthenolide, a potent and selective anti-leukemia agent

March 7, 2005

Pivotal trial begins for FK-228 for CTCL

March 4, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026